FILTER

FILTERED INTERVIEW RESULTS

John Huang

CEO, THEWELL BIOSCIENCE

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

TheWell Bioscience is a biomedical technology company providing innovative 3D cell platforms for drug discovery, cell therapy and personalized medicine.

United States

Pharma & Life Sciences

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

Ascendia Pharmaceuticals recounts the requirements to succeed in the CDMO space.

United States

Pharma & Life Sciences

Jigar Raythatha

PRESIDENT & CEO, CONSTELLATION PHARMACEUTICALS

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

Constellation Pharmaceuticals explains its therapy for myelofibrosis and introduces its discovery engine.

United States

Pharma & Life Sciences

Brad Payne & Chris Blanton & Morgan Brandt

COO & VP AND GENERAL MANAGER & GLOBAL DIRECTOR, DIGITAL PRODUCTS, PCI PHARMA SERVICES

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

PCI Pharma Services relates its rapid expansion in both services and geography.

United States

Pharma & Life Sciences

Michael Quirmbach

CEO & PRESIDENT, CORDENPHARMA

CordenPharma is enjoying great demand for its increasing array of services.

United States

Pharma & Life Sciences

Alan Petro

CEO, NEW VISION PHARMACEUTICALS

New Vision Pharmaceuticals explains how it is developing Blow-Fill-Seal technology and other services.

Thomas E. Bowens

FOUNDER AND PRESIDENT, IG GLOBAL GROUP & PRESIDENT AND CEO, TINTIC CONSOLIDATED METALS

Gold Report 2020/2021

Tintic Consolidated Metals explains to GBR how it is exploring the its’ vast gold/copper project in the Tintic district in Utah.

United States

Pharma & Life Sciences

Manni Kantipudi & Ramesh Subramanian

CEO & CCO, ARAGEN LIFE SCIENCES

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

Aragen Life Sciences continues its rapid expansion and celebrates its best year ever.

United States

Pharma & Life Sciences

Jose Antonio Moreno Toscano

CEO, LFB USA

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

LFB speaks to GBR as it begins the commercialization of Sevenfact and ATryn.

United States

Pharma & Life Sciences

Dr. Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS

United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive

ValGenesis explains how it streamlines the validation process to allow real-time access to validation documents and data enabling various stakeholders to achieve compliance efficiently.